Results of a Phase-I/II Randomized, Masked, Placebo-Controlled Trial of Recombinant Human Interleukin-11 (rhIL-11) in the Treatment of Subjects with Active Rheumatoid Arthritis

OpenBU

Files in this item

This item appears in the following Collection(s)

Search OpenBU


Advanced Search

Browse

Deposit Materials